Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Codexis Inc (CDXS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
EnzymeWorks, Inc. Retracts Prior Press Release

EnzymeWorks has been ordered by the United States District Court for the Northern District of California to retract its prior statements and press releases pertaining in any way to the settlement...

CDXS : 11.10 (unch)
New Research Coverage Highlights Alliance Resource Partners, MyoKardia, Pan American Silver, Stitch Fix, Codexis, and Chemical Financial -- Consolidated Revenues, Company Growth, and Expectations for 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Alliance Resource Partners,...

CDXS : 11.10 (unch)
SFIX : 20.22 (-1.37%)
PAAS : 17.30 (-1.14%)
ARLP : 16.35 (-1.51%)
MYOK : 49.60 (+1.64%)
CHFC : 56.09 (+0.70%)
Codexis Announces Pricing of Public Offering of Common Stock

Codexis, Inc. (Nasdaq:CDXS), a leading protein engineering company, today announced the pricing of an underwritten public offering of 3,750,000 shares of its common stock at a public offering price of...

CDXS : 11.10 (unch)
Codexis Announces Proposed Public Offering of Common Stock

Codexis, Inc. (Nasdaq:CDXS), a leading protein engineering company, today announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares to be sold in...

CDXS : 11.10 (unch)
Codexis to Present at H.C. Wainwright Global Life Sciences Conference in Monte Carlo, Monaco

Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at the H.C. Wainwright Global Life Sciences Conference on Tuesday, April 10, 2018 at 9:50 a.m....

CDXS : 11.10 (unch)
Origenis Appoints Dr. Peter Seufer-Wasserthal as Chief Business Officer

Origenis GmbH, a German biotech company specializing in the discovery and development of highly selective small molecule kinase inhibitors for CNS disorders, today announced the appointment...

CDXS : 11.10 (unch)
XON : 17.94 (-0.77%)
Codexis, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 8, 2018 / Codexis, Inc. (NASDAQ: CDXS) will be discussing their earnings results in their Q4 Earnings Call to be held on March 8, 2018, at 4:30 PM Eastern Time.

CDXS : 11.10 (unch)
Codexis to Hold 2017 Fourth Quarter and Full Year Conference Call on March 8

Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will report fourth quarter and full year 2017 financial results after market close on Thursday, March 8, 2018. Codexis...

CDXS : 11.10 (unch)
Codexis Appoints Molecular Diagnostics Industry Veteran Shawn Clairmont to Lead High-Performance Enzymes Commercialization

Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces the appointment of Shawn Clairmont to the newly created position of Senior Director, Molecular Diagnostics. Codexis is expanding...

CDXS : 11.10 (unch)
Codexis to Present at the 25th International Molecular Medicine Tri-Conference

Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that John Nicols, President & CEO, will discuss the development of an improved DNA ligase for the molecular diagnostics industry...

CDXS : 11.10 (unch)
Codexis Reports Financial Results for the Third Quarter of 2017

Product sales increase 71% over the prior year

CDXS : 11.10 (unch)
Codexis, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / November 9, 2017 / Codexis, Inc. (NASDAQ: CDXS) will be discussing their earnings results in their Q3 Earnings Call to be held on November 9, 2017 at 4:30 PM Eastern Time.

CDXS : 11.10 (unch)
Codexis to Present at Two Investment Conferences in November

Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at two investment conferences in November:

CDXS : 11.10 (unch)
Codexis to Hold 2017 Third Quarter Conference Call on November 9

Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will report third quarter 2017 financial results after market close on Thursday, November 9, 2017. Codexis management...

CDXS : 11.10 (unch)
Codexis and Nestle Health Science Enter Into Healthcare-Focused Protein Engineering Platform Partnership

-- Includes an option for the global development of CDX-6114 for PKU, marking Codexis' first partnership for an internally developed biotherapeutic product. Codexis receives an upfront payment of $14...

CDXS : 11.10 (unch)
Codexis to Present at Four Investment Conferences in September

Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at four investment conferences in September:

CDXS : 11.10 (unch)
EnzymeWorks, Inc. and Dr. Alex Tao Respond to Press Release by Codexis, Inc.

In response to a recent inaccurate press release by Codexis regarding the case Codexis, Inc. v. EnzymeWorks, Inc., Case No. 3:16-cv-00826-WHO (the "Case"), EnzymeWorks and Alex Tao, Ph.D.,...

CDXS : 11.10 (unch)
Codexis Reports Financial Results for the Second Quarter of 2017

Product sales more than doubled versus prior-year second quarter

CDXS : 11.10 (unch)
Investor Network: Codexis, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 9, 2017 / Codexis, Inc. (NASDAQ: CDXS) will be discussing their earnings results in their Q2 Earnings Call to be held on Wednesday, August 9, 2017 at 4:30 PM Eastern...

CDXS : 11.10 (unch)
Codexis Obtains Court Order Awarding Summary Judgment of Patent Infringement against EnzymeWorks

Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, on Tuesday secured a federal court order awarding it summary judgment on 10 claims of patent infringement it brought...

CDXS : 11.10 (unch)

Van Meerten Stock Picks

5 Great Mid Caps
This morning I wanted to find the Mid Cap stocks that not only had some of the best returns in the past 12 months but still seemed to have some upside potential.
IBKR +1.14 , HFC +0.02 , ABMD -0.53 , CAR -1.46 , URBN -1.09
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures weekly newsletter features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Friday morning to your inbox.

Brugler Ag Report

Today's Commentary

Corn futures closed the Friday session with 4 3/4 to 5 1/2 cent losses. Front month May was down 2.52% since last Friday. Friday’s CFTC Commitment of Traders report indicated spec funds in corn futures and options trimming their net long positi...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar